August 2nd, 2018
•Here we provide a detailed protocol to carry out in vivo cardiac gene editing in mice using recombinant Adeno-Associated Virus(rAAV)-mediated delivery of CRISPR. This protocol offers a promising therapeutic strategy to treat dystrophic cardiomyopathy in Duchenne muscular dystrophy and can be used to generate cardiac-specific knockout in postnatal mice.
Related Videos
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Establishment and Propagation of Human Retinoblastoma Tumors in Immune Deficient Mice
Production and Detection of Reactive Oxygen Species (ROS) in Cancers
Cardiac Stress Test Induced by Dobutamine and Monitored by Cardiac Catheterization in Mice
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis
Using Adeno-associated Virus as a Tool to Study Retinal Barriers in Disease
Development of an Alpha-synuclein Based Rat Model for Parkinson's Disease via Stereotactic Injection of a Recombinant Adeno-associated Viral Vector
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
Posterior Semicircular Canal Approach for Inner Ear Gene Delivery in Neonatal Mouse
Copyright © 2024 MyJoVE Corporation. 판권 소유